Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,824 | 71,232 | 111,184 | 127,965 | 169,912 |
| Receivables | N/A | 18,601 | 7,418 | N/A | 16,857 |
| Inventories | N/A | 52,997 | 41,973 | N/A | 18,525 |
| Other current assets | 0 | 0 | 0 | 39,396 | 0 |
| TOTAL | $72,928 | $149,265 | $165,181 | $175,410 | $214,394 |
| Non-Current Assets | |||||
| PPE Net | 12,566 | 17,794 | 19,115 | 17,614 | 23,566 |
| Investments And Advances | 0 | 0 | 1,401 | 1,401 | 1,401 |
| Other Non-Current Assets | 93,248 | 154,672 | 155,565 | 164,175 | 128,338 |
| TOTAL | $105,814 | $172,466 | $176,081 | $183,190 | $153,305 |
| Total Assets | $178,742 | $321,731 | $341,262 | $358,600 | $367,699 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,254 | 4,809 | 5,219 | 3,641 | 8,958 |
| Accrued Expenses | 48,233 | 86,356 | 76,317 | 22,509 | 54,158 |
| TOTAL | $64,833 | $108,282 | $98,478 | $98,659 | $79,225 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 102,494 | 102,009 | 101,544 | 101,135 |
| Deferred Revenues | N/A | 7,922 | 8,109 | N/A | 9,829 |
| Other Non-Current Liabilities | 89,990 | 102,665 | 105,149 | 203,253 | 107,398 |
| TOTAL | $89,990 | $300,523 | $302,522 | $304,797 | $303,597 |
| Total Liabilities | $154,823 | $408,805 | $401,000 | $403,456 | $382,822 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,537 | 7,587 | 7,572 | 7,550 | 6,463 |
| Common Shares | 170 | 152 | 151 | 135 | 129 |
| Retained earnings | -962,462 | -1,051,238 | -1,018,368 | -978,235 | -936,987 |
| TOTAL | $23,919 | $-87,074 | $-59,738 | $-44,856 | $-15,123 |
| Total Liabilities And Equity | $178,742 | $321,731 | $341,262 | $358,600 | $367,699 |